Probability of pregnancy with mono versus multiple folliculogenesis among women with unexplained infertility who are undergoing ovulation with gonadotropins, clomiphene or letrozole
Torie C. Plowden, Reproductive Medicine Network(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Robert A. Wild(Oklahoma City University), Nanette Santoro(University of Colorado Denver), Jason M. Franasiak(Reproductive Medicine Associates of New Jersey), Anne Z. Steiner(Northwestern University), Marcelle I. Cedars(University of California, San Francisco), Michael P. Diamond(Augusta University), Sunni L. Mumford(National Institutes of Health), Esther Eisenberg(University of Pittsburgh)
Cited by 2
Related Papers
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
|Fertility and Sterility|2011|2k
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
|The Journal of Clinical Endocrinology & Metabolism|2010|1k
Testing and interpreting measures of ovarian reserve: a committee opinion
|Fertility and Sterility|2020|606
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations
|Nature Communications|2015|542
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
|New England Journal of Medicine|2017|492